Mucinous Tumor
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei (NCT03976973) | Mucpharm Pty Ltd | 2022-05-01 |
| Phase I Trial HIPEC With Nal-irinotecan (NCT04088786) | Stony Brook University | 2019-10-22 |
Track Mucinous Tumor automatically
Every clearance here is in the API, with alerts when new ones post.